| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |